[1]Lago N，Rodriguez FJ，Guzman MS，et al.Effects of motor and sensory nerve transplants on amount and specificity of sciatic nerve regeneration.Journal of Neuroscience Research，2007，85(12)：2800-2812.

[2]Huang JH，Cullen DK，Browne KD，et al.Long-term survival and integration of transplanted engineered nervous tissue constructs promotes peripheral nerve regeneration.Tissue Eng Part A，2009，15(7)：1677-1685.

[3]Martinez AM，Goulart Cde O，Ramalho Bdos S，et al.Neurotrauma and mesenchymal stem cells treatment：From experimental studies to clinical trials.World journal of stem cells，2014，6(2)：179-194.

[4]Walsh SK，Kumar R，Grochmal JK，et al.Fate of stem cell transplants in peripheral nerves.Stem Cell Research，2012，8(2)：226-238.

[5]di Summa PG，Kalbermatten DF，Raffoul W，et al.Extracellular matrix molecules enhance the neurotrophic effect of Schwann cell-like differentiated adipose-derived stem cells and increase cell survival under stress conditions.Tissue Eng Part A，2013，19(3-4)：368-379.

[6]Faroni A，TerenghiG，Reid AJ.Adipose-derived stem cells and nerve regeneration：promises and pitfalls.Int Rev Neurobiol，2013，108：121-136.

[7]Hundepool CA，Nijhuis TH，Mohseny B，et al.The effect of stem cells in bridging peripheral nerve defects：ameta-analysis.Journal of Neurosurgery，2014，121(1)：195-209.

[8]Fairbairn NG，Meppelink AM，Ng-Glazier J，et al.Augmenting peripheral nerve regeneration using stem cells：A review of current opinion.World Journal of Stem Cells，2015，7(1)：11-26.

[9]Kemp SW，Walsh SK，Midha R.Growth factor and stem cell enhanced conduits in peripheral nerve regeneration and repair.Neurological Research，2008，30(10)：1030-1038.

[10]Chernousov MA，Yu WM，Chen ZL，et al.Regulation of Schwann cell function by the extracellular matrix.Glia，2008，56(14)：1498-1507.

[11]Geuna S，Gnavi S，Perroteau I，et al.Tissue engineering and peripheral nerve reconstruction：an overview.Int Rev Neurobiol，2013，108：35-57.

[12]Sachanandani NF，Pothula A，Tung TH.Nerve Gaps.Plastic and Reconstructive Surgery，2014，133(2)：313-319.

[13]Dai G，Liu X，Zhang Z，et al.Transplantation of autologous bonemarrow mesenchymal stem cells in the treatment of complete and chronic cervical spinal cord injury.Brain Research，2013，1533：73-79.

[14]Jiang PC，XiongWP，Wang G，etal.A clinical trial reportof autologous bonemarrow-derivedmesenchymal stem cell transplantation in patients with spinal cord injury.Experimental and Therapeutic Medicine，2013，6(1)：140-146.

[15]Aghayan HR，Goodarzi P，Arjmand B.GMP-compliant human adipose tissue-derived mesenchymal stem cells for cellular therapy.Methods Mol Biol，2015，1283：93-107.

[16]NicolettiGF，De Francesco F，D′Andrea F，et al.Methods and procedures in adipose stem cells：state of the art and perspective for translation medicine.Journal of Cellular Physiology，2015，230(3)：489-495.

[17]中华人民共和国卫生部第三类医疗技术审核办公室.干细胞制剂质量控制及临床前研究指导原则(试行).北京，2010.

[18]Barkholt L，Flory E，Jekerle V，et al.Risk of tumorigenicity in mesenchymal stromal cell-based therapies-bridging scientific observations and regulatory viewpoints.Cytotherapy，2013，15(7)：753-759.

[19]Diederichs S，Shine KM，Tuan RS.The promise and challenges of stem cell-based therapies for skeletal diseases：stem cell applications in skeletalmedicine：potential，cell sources and characteristics，and challenges of clinical translation.BioEssays：news and reviews in molecular，cellular and developmental biology，2013，35(3)：220-230.

[20]Dogan A，Dogdu O，Ozdogru I，et al.Cardiac effects of chronic graft-versus-host disease after stem cell transplantation.Texas Heart Institute journal/from the Texas Heart Institute of St.Luke′s Episcopal Hospital，Texas Children′s Hospital，2013，40(4)：428-434.

[21]胥少汀，葛宝丰，徐印坎主编.实用骨科学.第3版.北京：人民军医出版社，2005：934-943.

[22]Lin CS，Xin ZC，Dai JC，et al.Commonly used mesenchymal stem cell markers and tracking labels：Limitations and challenges.Histology and Histopathology，2013，28(9)：1109-1116.